These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 14562863)
21. A randomised, open-label comparison of three highly active antiretroviral therapy regimens including two nucleoside analogues and indinavir for previously untreated HIV-1 infection: the OzCombo1 study. Carr A; Chuah J; Hudson J; French M; Hoy J; Law M; Sayer D; Emery S; Cooper DA AIDS; 2000 Jun; 14(9):1171-80. PubMed ID: 10894281 [TBL] [Abstract][Full Text] [Related]
23. Short communication metabolic and mitochondrial effects of switching antiretroviral-experienced patients to enfuvirtide, tenofovir and saquinavir/ritonavir. Miró O; Garrabou G; López S; Deig E; Vidal I; Infante AB; Cardellach F; Casademont J; Pedrol E Antivir Ther; 2006; 11(5):625-30. PubMed ID: 16964831 [TBL] [Abstract][Full Text] [Related]
24. Mitochondrial proliferation, DNA depletion and adipocyte differentiation in subcutaneous adipose tissue of HIV-positive HAART recipients. Pace CS; Martin AM; Hammond EL; Mamotte CD; Nolan DA; Mallal SA Antivir Ther; 2003 Aug; 8(4):323-31. PubMed ID: 14518702 [TBL] [Abstract][Full Text] [Related]
25. Depletion of mitochondrial DNA in HIV-1-infected patients and its amelioration by antiretroviral therapy. Miura T; Goto M; Hosoya N; Odawara T; Kitamura Y; Nakamura T; Iwamoto A J Med Virol; 2003 Aug; 70(4):497-505. PubMed ID: 12794710 [TBL] [Abstract][Full Text] [Related]
26. Exploring mitochondrial nephrotoxicity as a potential mechanism of kidney dysfunction among HIV-infected patients on highly active antiretroviral therapy. Côté HC; Magil AB; Harris M; Scarth BJ; Gadawski I; Wang N; Yu E; Yip B; Zalunardo N; Werb R; Hogg R; Harrigan PR; Montaner JS Antivir Ther; 2006; 11(1):79-86. PubMed ID: 16518963 [TBL] [Abstract][Full Text] [Related]
27. Quantitation of blood lymphocyte mitochondrial DNA for the monitoring of antiretroviral drug-induced mitochondrial DNA depletion. Petit C; Mathez D; Barthélémy C; Leste-Lasserre T; Naviaux RK; Sonigo P; Leibowitch J J Acquir Immune Defic Syndr; 2003 Aug; 33(4):461-9. PubMed ID: 12869834 [TBL] [Abstract][Full Text] [Related]
28. Mitochondrial evolution in HIV-infected children receiving first- or second-generation nucleoside analogues. Morén C; Noguera-Julian A; Garrabou G; Catalán M; Rovira N; Tobías E; Cardellach F; Miró Ò; Fortuny C J Acquir Immune Defic Syndr; 2012 Jun; 60(2):111-6. PubMed ID: 22362155 [TBL] [Abstract][Full Text] [Related]
29. Mitochondrial Toxicogenomics for Antiretroviral Management: HIV Post-exposure Prophylaxis in Uninfected Patients. Bañó M; Morén C; Barroso S; Juárez DL; Guitart-Mampel M; González-Casacuberta I; Canto-Santos J; Lozano E; León A; Pedrol E; Miró Ò; Tobías E; Mallolas J; Rojas JF; Cardellach F; Martínez E; Garrabou G Front Genet; 2020; 11():497. PubMed ID: 32528527 [No Abstract] [Full Text] [Related]
30. Evidence of Subclinical mtDNA Alterations in HIV-Infected Pregnant Women Receiving Combination Antiretroviral Therapy Compared to HIV-Negative Pregnant Women. Money DM; Wagner EC; Maan EJ; Chaworth-Musters T; Gadawski I; van Schalkwyk JE; Forbes JC; Burdge DR; Albert AY; Lohn Z; Côté HC; PLoS One; 2015; 10(8):e0135041. PubMed ID: 26247211 [TBL] [Abstract][Full Text] [Related]
31. Mitochondrial DNA and RNA increase in peripheral blood mononuclear cells from HIV-1-infected patients randomized to receive stavudine-containing or stavudine-sparing combination therapy. Casula M; Weverling GJ; Wit FW; Timmermans EC; Stek M; Lange JM; Reiss P J Infect Dis; 2005 Nov; 192(10):1794-800. PubMed ID: 16235179 [TBL] [Abstract][Full Text] [Related]
32. Changes in the peripheral blood mtDNA levels in naive patients treated by different nucleoside reverse transcriptase inhibitor combinations and their association with subsequent lipodystrophy. Chêne G; Amellal B; Pédrono G; Gourlain K; Rancinan C; Journot V; Cotte L; Palmer P; Castro ND; Calvez V; Molina JM; AIDS Res Hum Retroviruses; 2007 Jan; 23(1):54-61. PubMed ID: 17263633 [TBL] [Abstract][Full Text] [Related]
33. Mitochondrial effects of a 24-week course of pegylated-interferon plus ribavirin in asymptomatic HCV/HIV co-infected patients on long-term treatment with didanosine, stavudine or both. Ballesteros AL; Miró O; López S; Fuster D; Videla S; Martínez E; Garrabou G; Salas A; Côté H; Tor J; Rey-Joly C; Planas R; Clotet B; Tural C Antivir Ther; 2004 Dec; 9(6):969-77. PubMed ID: 15651755 [TBL] [Abstract][Full Text] [Related]
35. Plasma Mitochondrial DNA Levels as a Biomarker of Lipodystrophy Among HIV-infected Patients Treated with Highly Active Antiretroviral Therapy (HAART). Dai Z; Cai W; Hu F; Lan Y; Li L; Chung C; Caughey B; Zhang K; Tang X Curr Mol Med; 2015; 15(10):975-9. PubMed ID: 26592244 [TBL] [Abstract][Full Text] [Related]
36. Mitochondrial (mt)DNA changes in tissue may not be reflected by depletion of mtDNA in peripheral blood mononuclear cells in HIV-infected patients. Maagaard A; Holberg-Petersen M; Kollberg G; Oldfors A; Sandvik L; Bruun JN Antivir Ther; 2006; 11(5):601-8. PubMed ID: 16964828 [TBL] [Abstract][Full Text] [Related]
37. Serum lactate levels in infants exposed peripartum to antiretroviral agents to prevent mother-to-child transmission of HIV: Agence Nationale de Recherches Sur le SIDA et les Hépatites Virales 1209 study, Abidjan, Ivory Coast. Ekouevi DK; Touré R; Becquet R; Viho I; Sakarovitch C; Rouet F; Towne-Gold B; Fassinou P; Leroy V; Blanche S; Dabis F; Pediatrics; 2006 Oct; 118(4):e1071-7. PubMed ID: 16950945 [TBL] [Abstract][Full Text] [Related]
38. Relationship between HIV/Highly active antiretroviral therapy (HAART)-associated lipodystrophy syndrome and stavudine-triphosphate intracellular levels in patients with stavudine-based antiretroviral regimens. Domingo P; Cabeza MC; Pruvost A; Salazar J; Gutierrez Mdel M; Mateo MG; Domingo JC; Fernandez I; Villarroya F; Muñoz J; Vidal F; Baiget M Clin Infect Dis; 2010 Apr; 50(7):1033-40. PubMed ID: 20192724 [TBL] [Abstract][Full Text] [Related]
39. Transplacentally exposed human and monkey newborn infants show similar evidence of nucleoside reverse transcriptase inhibitor-induced mitochondrial toxicity. Divi RL; Leonard SL; Kuo MM; Nagashima K; Thamire C; St Claire MC; Wade NA; Walker VE; Poirier MC Environ Mol Mutagen; 2007; 48(3-4):201-9. PubMed ID: 16538687 [TBL] [Abstract][Full Text] [Related]
40. Evolution of mitochondrial DNA content after planned interruption of HAART in HIV-infected pediatric patients. Noguera A; Morén C; Rovira N; Sànchez E; Garrabou G; Nicolàs M; Muñoz-Almagro C; Cardellach F; Miró O; Fortuny C AIDS Res Hum Retroviruses; 2010 Sep; 26(9):1015-8. PubMed ID: 20707732 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]